Clinical manifestations of postterm pregnancy include:
Maternal weight loss (more than 1.4 kg [approximately 3 lb]/week)
Decreased uterine size (related to decreased amniotic fluid)
Meconium in the amniotic fluid
Advanced bone maturation of the fetal skeleton with an exceptionally hard fetal skull
Association of Professors of Gynecology and Obstetrics (2015, September 10). Topic 30: Postterm Pregnancy: https://www.youtube.com/watch?v=cRVuSpPlx0c&list=PLy35JKgvOASnHHXni4mjXX9kwVA_YMDpq&index=22
The maternal risks of postterm pregnancy include:
Labor dystocia
Severe perineal injuries
Chorioamnionitis
Endomyometritis
Postpartum hemorrhage
Cesarean birth
For the fetus, here is an increased incidence of operative birth and shoulder dystocia, leading to fetal injury. Other fetal risks associated with postterm gestation are related to the intrauterine environment:
Decreased amniotic fluid
Potential for cord compression and resulting hypoxemia
Meconium-stained amniotic fluid
Increased risk for meconium aspiration
Fetal characteristics when overdue include:
Decreased subcutaneous fat
Lacks lanugo and vernix
Dry, cracked, peeling skin
Long nails
Meconium staining of skin, nails, and umbilical cord
Care management for postterm pregnancy includes:
Fetal surveillance: NST, contraction stress test (CST), BPP, or modified BPP
If cervix is favorable, labor can be induced at 41 weeks of gestation
Assess fetal activity daily
Assess for signs of labor
The woman should keep appointments with her obstetric health care provider.
If oligohydramnios is present, an amnioinfusion may be performed to restore amniotic fluid.
Interventions
Induction of labor with prostaglandins or oxytocin
Forceps- or vacuum-assisted birth
Cesarean birth
Complications:
Abnormal fetal growth
Small for gestational age
Macrosomia
Induction of labor is the chemical or mechanical initiation of uterine contractions before their spontaneous onset for the purpose of bringing about birth. Chemical, mechanical, physical, and alternative methods are used to induce labor. IV oxytocin (Pitocin) and amniotomy are the most common methods.
Labor may be induced for indicated reasons, including:
Risk of continuing the pregnancy becomes more dangerous for either the mother or the fetus
No contraindications for artificial rupture of the membranes (amniotomy)
No contraindication for augmenting uterine contractions with oxytocin
Elective induction is when labor is initiated without a medical indication. To prevent iatrogenic prematurity, elective induction of labor should not be initiated until the woman reaches at least 39 completed weeks to ensure adequate fetal lung maturity.
Giorux, M. (2019, January). Intrapartum Care: Shoulder Dystocia OBGYNAcademy. https://obgynacademy.com/intrapartum-care/
Success rates for induction of labor are higher when the condition of the cervix is favorable, or inducible. The Bishop score is a rating system to determine favorability of cervix for induction. A score of eight or more on this 13-point scale indicates that the cervix is soft, anterior, 50% or more effaced, and dilated 2 cm or more, and that the presenting part is engaged. If the Bishop score totals eight or more, the likelihood of vaginal birth is similar whether labor is spontaneous or induced.
Medications and Chemical Agents
Preparations of prostaglandins E1 (PGE1) and E2 (PGE2) have been shown to be effective when used before induction to “ripen” (soften and thin) the cervix. The advantages of prostaglandin use for cervical ripening include:
Decreased oxytocin induction time
Decrease in the amount of oxytocin required for successful induction
Cervidil ® (dinoprostone 10mg) is a time released synthetic prostaglandin used for cervical ripening. It is placed by a provider in the vagina behind the cervix to remain for 12 hours, when labor begins (either spontaneously or by induction), or uterine hyperstimulation. The medication is wrapped in a knitted polyester pouch that will be left outside of the vagina so it can easily be pulled when needed.
Ferring Pharmaceuticals (2023). Proper Administration of Cervidil: https://www.cervidil.com/hcp/administration-dosage/#play-video
Misoprostol is a synthetic analouge of prostaglandin E1 used fro treatment of gastric ulcers; it also has uterotonic properties of contracting the uterus and relaxing the cervix. A small dose of 25 to 50 micrograms is administered orally or vaginally every 4 hours until labor is established.
Amniotic Membrane Stripping
Amniotic membrane stripping or sweeping is a method of inducing labor through the release of prostaglandins and oxytocin. The procedure involves separation of the membrane from the wall of the cervix and lower uterine segment by inserting a finger into the internal cervical os and rotating it 360 degrees.
Physical Methods
Physical methods include:
Sexual intercourse (prostaglandins in the semen and stimulation of contractions with orgasm)
Nipple stimulation (release of endogenous oxytocin from the pituitary gland)
Walking (gravity applies pressure to the cervix, which stimulates the secretion of endogenous oxytocin) may be used by women to “self-induce” labor
Mechanical Methods
Mechanical dilators ripen the cervix by stimulating the release of endogenous prostaglandins. This method includes:
Balloon catheters can be inserted through the intracervical canal to ripen and dilate the cervix. The process results in pressure and stretching of the lower uterine segment and the cervix, as well as the release of endogenous prostaglandins.
The Cook ® Cervical Ripening Balloon is developed for this use, but a foley ballon catheter can also be used if it is the only option.
Sana Teb (2021, February 2). Cook Cervical Ripening Balloon: https://www.youtube.com/watch?v=rhzbmcVKZYs
Hydroscopic dilators (substances that absorb fluid from surrounding tissues and then enlarge) also can be used for cervical ripening. This method includes:
Laminaria tents (natural cervical dilators made from desiccated seaweed) and synthetic dilators containing magnesium sulfate (Lamicel) are inserted into the endocervix without rupturing the membranes. As they absorb fluid, they expand and cause cervical dilation and the release of endogenous prostaglandins. These dilators are left in place for 6 to 12 hours before being removed to assess cervical response.
Nursing responsibilities for women who have dilators inserted include the following:
Documenting the number of dilators and sponges inserted during the procedure, as well as the number removed
Assessing for urinary retention, rupture of membranes, uterine tenderness or pain, contractions, vaginal bleeding, infection, and fetal distress
Oxytocin is a hormone normally produced by the posterior pituitary gland. It stimulates uterine contractions and aids in milk ejection (let-down). Synthetic oxytocin (Pitocin) may be used either to induce labor or to augment labor. However, it can present hazards to the mother and fetus. The goal of oxytocin use is to produce contractions of normal intensity, duration, and frequency using the lowest dose of medication possible.
Oxytocin is given intravenously and begins at a small dose, increasing every 15-30 minutes until labor is occurring. Typical dosing involves:
Starting dose of 1-2mu/min, increasing by 1-2 mu/min every 15 minutes to a maximum of 20mu/min
Some physicians advocate active management of labor-augmentation to establish efficient labor with the aggressive use of oxytocin so that the woman gives birth within 12 hours of admission to the labor unit. This involves:
Starting dose of 4-6 mu/min, increaing by 6mu/min every 15 minutes to a maximum of 36mu/min
Maternal hazards of any uterotonic medication include:
Placental abruption
Uterine rupture
Unnecessary cesarean birth because of abnormal FHR and pattern
Postpartum hemorrhage
Infection
Signs of uterine tachysystole include:
More than five contractions in 10 minutes or
A series of single contractions lasting greater than 2 minutes or
Contractions of normal duration occurring within 1 minute of each other.
Interventions (with normal [category I] FHR tracing):
Reposition or maintain woman in side-lying position (either side).
Administer IV fluid bolus with 500 ml of lactated Ringers solution.
If uterine activity has not returned to normal after 10 min, decrease the oxytocin dose by at least half.
If uterine activity has not returned to normal after another 10 min, discontinue the oxytocin infusion until fewer than five contractions occur in 10 min.
Interventions (with indeterminate [category Ⅱ] or abnormal [category Ⅲ] FHR tracing):
Discontinue oxytocin infusion immediately.
Reposition or maintain woman in side-lying position (either side).
Administer IV fluid bolus with 500 ml of lactated Ringers solution.
Consider giving oxygen at 10 L/min via nonrebreather face mask if the above interventions do not resolve the indeterminate or abnormal (category Ⅱ or category Ⅲ) FHR tracing.
If still no response, consider giving 0.25 mg terbutaline subcutaneously according to unit protocol or standing orders.
Notify obstetric health care provider of actions taken and maternal and fetal response.
Resumption of oxytocin after resolution of tachysystole:
If the oxytocin infusion has been discontinued for less than 20–30 min, resume at no more than one-half the rate that caused the tachysystole.
If the oxytocin infusion has been discontinued for more than 30–40 min, resume at the initial starting dose.
Amniotomy
Amniotomy (the artificial rupture of membranes, or AROM) can be used to induce labor when the condition of the cervix is favorable (ripe) or to augment labor if progress begins to slow. Labor usually begins within 12 hours of AROM.
Augmentation of labor is the stimulation of uterine contractions after labor has started spontaneously and progress is unsatisfactory. It is usually implemented to manage hypotonic uterine dysfunction that resulted in a slowing of the labor process (protracted active phase).
Augmentation methods include:
Oxytocin infusion
Amniotomy
Emptying the bladder
Ambulation
Position changes
Relaxation measures
Nourishment
Hydration
Hydrotherapy
For information on hypotonic uterine dysfunction, see the section on Dysfunctional Labor
American College of Obstetricians and Gynecologists (2014). Management of Late-Term and Postterm Pregnancies: Practice Bulletin Number 146: https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2014/08/management-of-late-term-and-postterm-pregnancies
Chatsis, V & Frey, N. (2018). Misoprostol for Cervical Ripening and Induction of Labour: A Review of Clinical Effectiveness, Cost Effectieness, and Guidelines. National Library of Medicine: https://www.ncbi.nlm.nih.gov/books/NBK538944/
Galal, M., Symonds, I., Murray, H., Petraglia, F., & Smith, R. (2012), Facts, Views, and Vision in ObGyn, 4(3): 175-187. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991404/#:~:text=Definitions,to%20describe%20the%20same%20condition.